Daily non-political popular news in brief.
OHSU researchers: Surgery, radiation gives early survival advantage in bile duct cancer
10-28-2007 · EurekAlert!Oregon Health & Science University researchers are reporting the discovery of an early survival advantage when a combination of surgery and radiation therapy is used for patients with a rare but deadly bile duct cancer. "Surgery and radiotherapy shows an early response benefit. It shows that the addition of radiation is potentially reasonable for the first-line treatment," said Clifton David Fuller, M.D., Ph.D., principal investigator of the study.
Read more »
Keywords: ohsu, researchers, surgery, radiation, survival, advantage, bile, duct, cancer, researcher
« Previous | Next »
Similar news on "OHSU researchers: Surgery, radiation gives early survival advantage in bile duct cancer":
- OHSU Cancer Institute researcher identifies protein marker for prostate cancer survival
06-01-2007 · EurekAlert!
Oregon Health & Science University Cancer Institute researchers have identified a protein that is a strong indicator of survival for men with advanced prostate cancer. The C-reactive protein, also known as CRP, is a special type of protein produced by the liver that is elevated in the presence of inflammation.
Similar news · Read more »
- Mayo Clinic Cancer Center -- Surgery and adjuvant therapy may work for pancreatic cancer
01-20-2007 · EurekAlert!
In the largest single-institution retrospective study to date, researchers at Mayo Clinic Cancer Center have shown that giving patients both radiation and chemotherapy after completely removing invasive pancreatic cancer may improve overall survival rates.
Similar news · Read more »
- Tumors stopped from spreading to new sites
04-05-2007 · EurekAlert!
For several types of cancer, persistently high levels of the soluble factor TGF-beta in the blood after surgery, chemotherapy, or radiation therapy correlate with increased risk of early metastasis and a poor prognosis. Using a mouse model of breast cancer, researchers from Vanderbilt University have now generated evidence to suggest that treatment with TGF-beta inhibitors might help such patients.
Similar news · Read more »
- Positioning pelvic cancer patients on stomachs for radiation yields better results
10-28-2007 · EurekAlert!
Oregon Health & Science University Cancer Institute researchers have found that positioning pelvic cancer patients on their stomachs rather than their backs is a better method for delivering radiation therapy. Because patients return for multiple therapies, being able to reproduce the positioning of the patient allowed more precision, which reduces toxicity. "It was a surprising finding," according to according to Martin Fuss, M.D., the director of the Program in Image-Guided Radiation Therapy, OHSU Radiation Medicine.
Similar news · Read more »
- Order of chemotherapy, radiation has no effect on breast cancer survival
10-30-2006 · EurekAlert!
For women who have had surgery for early breast cancer, it may not matter whether they receive follow-up chemotherapy before, after or during radiation therapy, according to a new review of studies.
Similar news · Read more »
- OHSU Cancer Institute, VA researchers find way to identify which men need a second biopsy
06-02-2007 · EurekAlert!
A researcher in the Oregon Health & Science University Cancer Institute and Portland Veterans Affairs Medical Center has found a way to identify which men need a second prostate biopsy because they may be harboring life-threatening prostate cancer even though they were given a clean bill of health after their first biopsy.
Similar news · Read more »
- OHSU Cancer Institute researcher discovers what fuels certain cancer mutation
12-10-2007 · EurekAlert!
An Oregon Health & Science University Cancer Institute researcher has discovered that a particular hormone is responsible for driving a cancer enzyme to cause an often deadly red blood cell cancer. Researchers working with the cancer mutation in the JAK2 enzyme have found that the enzyme is dependent on the hormone TNF-alpha to grow and cause a red blood cell cancer called polycythemia vera, said principal investigator Thomas Bumm, M.D., Ph.D., OHSU Cancer Institute member.
Similar news · Read more »
- PET scans track small tumors after stereotactic body radiotherapy
10-28-2007 · EurekAlert!
Readily available CT screening for lung cancer is increasing the discovery of small, primary lung cancers. For many, a radiation technique called stereotactic body radiotherapy presents a less invasive treatment option to surgery that is typically offered to nonsurgical candidates. In a study presented today researchers present data showing metabolic response monitored by FDG PET may be an early surrogate for local treatment failure which may allow timely salvage surgery if deemed necessary.
Similar news · Read more »
- Marker predicts pancreatic cancer outcome after surgery, Jefferson surgeon finds
06-22-2007 · EurekAlert!
A team of researchers, led by surgeons at the Kimmel Cancer Center at Jefferson in Philadelphia, has found further evidence supporting the ability of a protein to predict how well a patient with advanced pancreatic cancer will do after surgery, chemotherapy and radiation.
Similar news · Read more »
- Skin rash actually signifies better outcomes for pancreatic and lung cancer patients
07-03-2007 · EurekAlert!
The appearance of a rash in cancer patients treated with erlotinib (Tarceva) is strongly associated with longer survival, according to researchers from the drug’s developer, OSI Pharmaceuticals, Inc. This is not the first time that rash has been associated with a survival advantage with EGFR inhibitors -- a class of drugs which includes erlotinib, cetuximab, panitumumab and others designed to block overproduction of the epidermal growth factor receptor -- but it is the most detailed analysis to date.
Similar news · Read more »
